GeneDx Files IPRs Against Myriad

GeneDx Inc., one of Myriad's litigation opponents in the infamous BRCA litigation which resulted in two Myriad patents being invalidated, has filed 11 petitions for inter partes review of patents owned, co-owned, or licensed by Myriad.

http://www.nationallawjournal.com/home/id=1202667340255/Inter-Partes-Challenge-Filed-Against-Myriad-Patents?mcode=1202617074964&curindex=1&slreturn=20140720140255